Leading scientists Jeremy Farrar, Marion Koopmans, and Ron Fouchier will take you into the world of new infectious diseases outbreaks and show you how we can prepare for these outbreaks.
The outbreaks of the past decade have taught us that new infectious diseases continue to emerge and spread as a result of global changes. These changes include population growth, an increase in livestock and agriculture to feed the population, exponential growth of travel (tourism and trade), and climate change. Infectious diseases do not confine themselves to national borders and can spread globally, as has been shown by Zika, Ebola, MERS, and bird flu viruses. What these outbreaks have in common is that they arise unexpectedly and put our healthcare systems to the test. When an outbreak occurs, it is often difficult to intervene because there is a lack of reliable diagnostics, treatment, and vaccines at short notice.
Masterclass with Jeremy Farrar, Marion Koopmans, Ron Fouchier
Date: Thursday 4 October
Time: 15.00 – 17.00
Location: Erasmus MC, Rotterdam
Registration via: [email protected]
The NCOH wants to build a research programme which sharpens the NCOH profile and increases scientific production of the NCOH during its first mandate period. This goal is reached by accelerating the investments of NCOH Partners.
People who live near livestock farms have an increased risk of pneumonia. In areas with many livestock farms, the presence of a farm can explain up to 20% of all lung infection cases, but the pathogens responsible are as yet unknown. Researchers from Utrecht University’s Institute for Risk Assessment Sciences, Erasmus MC, and UMC Utrecht...
ESBL is an enzyme, produced by certain bacteria, which makes these bacteria resistant to antibiotics. Researchers from various institutes collaborating in a large consortium discovered that ESBLs occur frequently in livestock, the food chain, the environment and also in humans.
Bacteriophages received considerable attention in the lay press in the Netherlands recently. To optimally design trials to provide the necessary evidence UMC Utrecht invited international experts in bacteriophage therapy to present their experiences with this approach on 22 February in Utrecht.